Welcome

Glykoz is a Glycomics Discovery company, delivering next generation pharmaceuticals to market by combining world-leading expertise in medicinal chemistry, clinical microbiology and drug discovery. Immediate focus is on a revolutionary advancement in the treatment of infectious diseases.

Glycopharmaceuticals promise a new avenue for the control of a variety of disorders, including cancer, chronic inflammation, infections and immune dysfunction.

Glykoz is developing its technology platform and carbohydrate expertise to produce a sustainable pipeline for the discovery of new drug candidates.